Clinical pharmacy in surgery : Role of the pharmacist in a CRIOAC
Seance of wednesday 14 february 2024 (Apport de la médecine polyvalente hospitalière dans un service de chirurgie)
DOI number : 10.26299/ms55-vk71/emem.2024.06.04
Abstract
Osteoarticular infections (OAI) are complex infections requiring multidisciplinary management and long-term antibiotic therapy. The pharmacist has become essential for optimizing and securing the medicinal treatment of these patients, due to their complexity (multi-pathological patients, poly-medicated patients, often elderly, with extreme weights and the use of molecules or therapeutic doses off-label, etc.).
The role of the clinical pharmacist in a reference center for osteoarticular infections (CRIOAC) is to carry out medication reconciliations for patients to have a reliable basis for their treatments taken at home. Then, the pharmaceutical analysis of the prescriptions is carried out in order to adapt the medications according to the kidney function and the weight of the patient.
When the patient is discharged, the pharmacist explains to the patient the anti-infective treatment implemented, the therapeutic modifications made to avoid drug interactions and provides instructions regarding the treatment and its possible side effects.
This is multidisciplinary work, which makes it possible to create a hospital-city link. The various activities carried out aim to reduce the risk of drug-induced iatrogenics. The patient is at the heart of this process to make him an actor in his health.
The role of the clinical pharmacist in a reference center for osteoarticular infections (CRIOAC) is to carry out medication reconciliations for patients to have a reliable basis for their treatments taken at home. Then, the pharmaceutical analysis of the prescriptions is carried out in order to adapt the medications according to the kidney function and the weight of the patient.
When the patient is discharged, the pharmacist explains to the patient the anti-infective treatment implemented, the therapeutic modifications made to avoid drug interactions and provides instructions regarding the treatment and its possible side effects.
This is multidisciplinary work, which makes it possible to create a hospital-city link. The various activities carried out aim to reduce the risk of drug-induced iatrogenics. The patient is at the heart of this process to make him an actor in his health.